Authors


Milena Anatchkova, PhD

Latest:

A Computerized Asthma Outcomes Measure Is Feasible for Disease Management

The ASTHMA-CAT, an online, patient-based assessment measure, may facilitate asthma care management.


Todd N. Bisping, BS, MBA

Latest:

Caterpillar Breaks New Ground Managing the Prescription Drug Supply Chain

By eliminating waste in the prescription drug supply chain, Caterpillar lowered total drug costs while copayment tiers remained unchanged.


Gary Keil, PhD, RPh

Latest:

Perserverance After Match Day Uncertainty Leads to Opportunity

Match day can be one of the most uplifting, validating, and encouraging of days.


Simon D. Murray, MD

Latest:

NASP 2019: A Doctor's Perspective on Specialty Pharmacy

The annual National Association of Specialty Pharmacy annual meeting shed light on the significant role these caregivers play in patient care.



Jaime Rosenberg

Latest:

Phase 3 Data Favor Bimekizumab Over Placebo in Biologic-Naïve Patients With Psoriatic Arthritis

All primary and ranked secondary endpoints of the study were met at week 16, which were sustained or improved through week 24 and were coupled with patient-reported improvements compared with placebo in treating psoriatic arthritis.


Gina Koskosky

Latest:

ADA's New CEO Takes Over in Time for 78th Scientific Sessions

Tracey D. Brown will welcome 16,000 attendees to the premier diabetes health care conference in her first month as chief executive of the American Diabetes Association.



Thomas Walczyk, 2017 PharmD Candidate

Latest:

Opportunistic Infections: Better Have a Pharmacist Onboard

Approximately 1.2 million individuals live with HIV/AIDS in the United States. This population is at an increased risk of opportunistic infections (OIs), an area where pharmacists have significant potential to make meaningful interventions.


Kathleen Wilson, MPH

Latest:

Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic Arthritis

For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.



Hyungwon Kim, PharmD candidate

Latest:

Lasmiditan For the Acute Treatment of Migraine: An Opportunity For Pharmacists

Despite triptan availability as a migraine-specific rescue, the global burden of migraine morbidity remains high.


Kerry Philbeck, QS/1 Staff Writer

Latest:

Sav-Mor Pharmacy: Marketing From the Inside Out

The Illinois pharmacy chain has attained success as a result of good planning and successful marketing strategies.


Roy Goo, PharmD

Latest:

Association Between Sustained Glycated Hemoglobin Control and Healthcare Costs

Total cost of care for patients whose glycated hemoglobin levels were


Therese M. Conner, PhD

Latest:

Review of Outcomes Associated With Formulary Restrictions: Focus on Step Therapy

As healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.



Myroslava Sharabun, PharmD Candidate

Latest:

Cancer Screening: Let's Talk About It

Over the past 2 decades, the cancer death rate has drastically declined in the United States, falling 23% from its 1991 peak. This translates to 1.7 million lives saved.


Frances R. Blevins, PA-C

Latest:

A New Monoclonal Antibody for R/R MM: Isatuximab-irfc

Isatuximab-ifrc is the third monoclonal antibody approved for the treatment of R/R MM.


Julie Slezak, MS

Latest:

A Look Into 2011 Drug Utilization Trend and Beyond

Significant factors for 2011 prescription utilization include the recession, change in employment rate, new generic and brand launches, and changes in Baby Boomers' retirement plans.


Lee Goldberg

Latest:

Managed Care Biologics and Injectables

Payer response to new entrants to the multiple sclerosis (MS) market is mixed as some believe that there remain meaningful, major unmet needs in the MS category, according to The Zitter Group's Spring 2011 Managed Care Biologics and Injectables Index.


Ayse Hursid, PharmD

Latest:

Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19

The COVID-19 pandemic made a convincing argument to employers of having a robust and sound communication strategy to their employees.


Katherine Summers, PharmD candidate

Latest:

Sodium-Glucose Cotransporter-2 Inhibitors for Treating Type 2 Diabetes

Diabetes is a complex disease affecting 29.1 million individuals in the United States.



David Cluck, PharmD, BCPS, AAHIVP

Latest:

HIV Infection: The Future of Therapy

Approximately 35 million individuals are currently living with HIV/AIDS.


John Toussaint, MD

Latest:

The Evolution of Accountable Care Organizations and the Role of Pharmacists

When an ACO succeeds in both delivering high-quality care and spending health care dollars more wisely, it will share in the savings it achieves for the Medicare program.


Niels Quist, JD

Latest:

The Use of Authorizations by Specialty Pharmacies to Provide Protected Health Information to Pharma

What are some of the pitfalls that a pharmacy needs to avoid when setting up a relationship with a pharma manufacturer to accept authorizations from individuals to release information to that manufacturer?



Brody McConnell, 2016 PharmD Candidate

Latest:

Does Phenylephrine Really Control Allergic Rhinitis Symptoms?

Allergic rhinitis is a condition that keeps noses and pharmacists running.



Alexa Boer Kimball, MD, MPH

Latest:

Malignant Melanoma: The Implications of Cost for Stakeholder Innovation

An activity-based cost accounting model of melanoma care was used to identify key cost drivers and opportunities for stakeholder innovation.